Washington

AstraZeneca says 4th-Q earns triple on cancer drugs sales – Washington, District of Columbia

Washington, District of Columbia 2021-02-11 02:45:56 –

London (AP) — AstraZeneca, which co-developed one of the first COVID-19 vaccines approved for widespread use, in the fourth quarter …

London (AP) — AstraZeneca, which co-developed one of the first COVID-19 vaccines approved for widespread use, tripled its fourth-quarter revenues in the strong sales of its anti-cancer drug. That’s all.

A British-Swedish company said Thursday that net income had increased from $ 313 million in the year-ago quarter to $ 1.01 billion.

With a 24% increase in cancer treatments, drug sales increased 11% to $ 7.41 billion.

The company said it will generate $ 2 million in revenue from the COVID-19 vaccine, which it promised to supply on a non-profit basis during a pandemic, and will begin reporting vaccine sales individually from the next quarter.

Copyright © 2021 AP communication. all rights reserved. This material may not be published, broadcast, written, or redistributed.

AstraZeneca says 4th-Q earns triple on cancer drugs sales Source link AstraZeneca says 4th-Q earns triple on cancer drugs sales

Back to top button